{
    "title": "US FDA approves GSK's bone marrow cancer therapy",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12524453/US-FDA-approves-GSKs-blood-cancer-therapy.html",
    "date": "2023-09-15",
    "keywords": [
        "therapy",
        "blood",
        "anemia",
        "cancer",
        "myelofibrosis",
        "approval",
        "momelotinib",
        "gsk",
        "drug",
        "hepcidin",
        "business",
        "sierra",
        "oncology",
        "year",
        "drugmaker",
        "plc",
        "friday",
        "food",
        "administration",
        "type",
        "bone",
        "marrow",
        "health",
        "regulator",
        "july",
        "decision",
        "statement",
        "ojjaara",
        "class",
        "protein",
        "body",
        "production",
        "deficiency",
        "cell",
        "count",
        "government",
        "latestage",
        "study",
        "disease",
        "cut",
        "dependence",
        "treatment",
        "danazol",
        "morningstar",
        "analyst",
        "damien",
        "conover",
        "market",
        "growth",
        "patent",
        "protection",
        "effort",
        "pipeline",
        "buyout",
        "developer",
        "trial",
        "payment",
        "milestone",
        "mariam",
        "sunny",
        "bhanvi",
        "satija",
        "bengaluru",
        "editing",
        "syamnath"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}